Boston Scientific Corporation EPS (Earnings per Share) 2007–2025
Boston Scientific Corporation reported $1.94 of earnings per share for fiscal 2025. That was 55.2% higher than fiscal 2024. Compared with fiscal 2020, the change was +2525.0%.
| Fiscal year | EPS (Earnings per Share) | Change (YoY) |
|---|---|---|
| FY 2025 | $1.94 | +55.2% |
| FY 2024 | $1.25 | +16.8% |
| FY 2023 | $1.07 | +137.8% |
| FY 2022 | $0.45 | -34.8% |
| FY 2021 | $0.69 | +962.5% |
| FY 2020 | $-0.08 | -102.4% |
| FY 2019 | $3.33 | +179.8% |
| FY 2018 | $1.19 | +1387.5% |
| FY 2017 | $0.08 | -68.0% |
| FY 2016 | $0.25 | +238.9% |
| FY 2015 | $-0.18 | -100.0% |
| FY 2014 | $-0.09 | +0.0% |
| FY 2013 | $-0.09 | +96.9% |
| FY 2012 | $-2.89 | -1096.6% |
| FY 2011 | $0.29 | +141.4% |
| FY 2010 | $-0.70 | -2.9% |
| FY 2009 | $-0.68 | +50.0% |
| FY 2008 | $-1.36 | -312.1% |
| FY 2007 | $-0.33 | — |
Source: Boston Scientific Corporation SEC filings — income statement (10-K), split-adjusted. Computed deterministically; refreshed nightly (last updated August 2, 2026). Open BSX 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Boston Scientific Corporation reported $1.94 of earnings per share for fiscal 2025. That was 55.2% higher than fiscal 2024. Compared with fiscal 2020, the change was +2525.0%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Boston Scientific Corporation
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeBoston Scientific Corporation — frequently asked questions
What is Boston Scientific Corporation's earnings per share?
Boston Scientific Corporation (BSX) reported earnings per share of $1.94 for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Boston Scientific Corporation's official SEC filings (income statement (10-K), split-adjusted), refreshed nightly. Not investment advice.